The results showed that periprocedural heparin is associated with an increased risk of unfavorable outcomes and SICH in patients treated with EVT after IVT. Further studies are warranted to evaluate the utility and safety of periprocedural heparin.
Keyphrases
- acute ischemic stroke
- venous thromboembolism
- direct oral anticoagulants
- percutaneous coronary intervention
- growth factor
- high dose
- catheter ablation
- acute coronary syndrome
- coronary artery disease
- atrial fibrillation
- type diabetes
- pulmonary embolism
- case control
- skeletal muscle
- insulin resistance
- aortic dissection
- weight loss